Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ciprofol plus alfentanil versus propofol plus alfentanil for painless gastrointestinal endoscopy
ChiCTR2200061132Phase 4Not yet recruiting
- Sponsor
- The First Affiliated Hospital of Zhengzhou University
- Start
- Jun 2022
- Modality
- Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of ciprofol, propofol and alfentanil (2 arms), sponsored by The First Affiliated Hospital of Zhengzhou University. Primary endpoint: Gastroscopy and colonoscopy success rate. Planned start Jun 2022; status: not yet recruiting.
02
Drugs
ciprofolpropofolalfentanil
Beyond the preview
Go deeper on ChiCTR2200061132.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200061132.